It is thought that gene conversion (GCV) and somatic hypermutation (SHM) of immunoglobulin (Ig) genes occur in two steps: the generation of uracils in DNA by activation-induced cytidine deaminase, followed by their subsequent repair by various DNA repair pathways to generate sequence-diversified products. It is not known how either of the two steps is targeted specifically to Ig loci. Because of the tight link between transcription and SHM, we have investigated the role of endogenous Ig light chain (IgL) transcriptional control elements in GCV/SHM in the chicken B cell line DT40. Promoter substitution experiments led to identification of a strong RNA polymerase II promoter incapable of supporting efficient GCV/SHM. This surprising finding indicates that high levels of transcription are not sufficient for robust GCV/SHM in Ig loci. Deletion of the IgL enhancer in a context in which high-level transcription was not compromised showed that the enhancer is not necessary for GCV/SHM. Our results indicate that cis-acting elements are important for Ig gene diversification, and we propose that targeting specificity is achieved through the combined action of several Ig locus elements that include the promoter.
Skip Nav Destination
Article navigation
25 December 2006
Article|
December 18 2006
Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences
Sebastian D. Fugmann,
Sebastian D. Fugmann
1Section of Immunobiology
2Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520
Search for other works by this author on:
David G. Schatz
David G. Schatz
1Section of Immunobiology
2Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520
Search for other works by this author on:
Shu Yuan Yang
1Section of Immunobiology
Sebastian D. Fugmann
1Section of Immunobiology
2Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520
David G. Schatz
1Section of Immunobiology
2Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520
CORRESPONDENCE David G. Schatz: [email protected]
Abbreviations used: AID, activation-induced cytidine deaminase; EF1-α, elongation factor 1-α; GCV, gene conversion; IgH, Ig heavy chain; Igκ, Ig light chain κ; IgL, Ig light chain; SHM, somatic hypermutation.
S.D. Fugmann's present address is National Institute on Aging, National Institutes of Health, Baltimore, MD 21224.
Received:
August 28 2006
Accepted:
November 20 2006
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2006
J Exp Med (2006) 203 (13): 2919–2928.
Article history
Received:
August 28 2006
Accepted:
November 20 2006
Citation
Shu Yuan Yang, Sebastian D. Fugmann, David G. Schatz; Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences . J Exp Med 25 December 2006; 203 (13): 2919–2928. doi: https://doi.org/10.1084/jem.20061835
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement